Showing results (161-170 of 298) with videos related to
Sort By:
Pageof 30
Cell Metabolism|January 1, 2013
AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivoBrandon Faubert, Gino Boily, Said Izreig, et al.The Journal of Clinical Investigation|September 29, 2015
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitmentChristopher G Peña, Yuji Nakada, Hatice D Saatcioglu, et al.Scientific Reports|November 26, 2015
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachoneGaurab Chakrabarti, Molly A Silvers, Mariya Ilcheva, et al.Nature|August 22, 2017
Ascorbate regulates haematopoietic stem cell function and leukaemogenesisMichalis Agathocleous, Corbin E Meacham, Rebecca J Burgess, et al.Proceedings of the National Academy of Sciences of the United States of America|May 13, 2022
SNAT7 regulates mTORC1 via macropinocytosisDelong Meng, Qianmei Yang, Mi-Hyeon Jeong, et al.The Journal of Clinical Investigation|July 15, 2026
SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activationHaojun Yang, Vincenzo Andrea Zingaro, Kevin Boardman, et al.Cancer Research|May 2, 2022
Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in GlioblastomaBo Zhang, Hui Peng, Mi Zhou, et al.Nature Communications|December 8, 2019
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancerAlba Luengo, Keene L Abbott, Shawn M Davidson, et al.Nature Genetics|October 21, 2015
NRF2 regulates serine biosynthesis in non-small cell lung cancerGina M DeNicola, Pei-Hsuan Chen, Edouard Mullarky, et al.Cancer & Metabolism|October 14, 2015
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachoneGaurab Chakrabarti, Zachary R Moore, Xiuquan Luo, et al.Pageof 30